STOCK TITAN

Mettler-Toledo Financials

MTD
Source SEC Filings (10-K/10-Q) Updated May 8, 2026 Currency USD FYE December

This page shows Mettler-Toledo (MTD) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MTD FY2025

High-margin, low-capex operations turn a little over $4.0B of sales into cash that largely funds persistent share repurchases.

Over the last three years, free cash flow stayed near $850M while share buybacks ran at a similar level, which helps explain why equity remained negative and cash stayed below $70M even with steady profits. The stretched-looking balance sheet is therefore partly a result of capital return policy; the operating engine still produced free cash flow margins above 21% in each of those years.

Cash conversion is unusually tight: operating cash flow of $956M became $849M of free cash flow, meaning most cash earnings survived after reinvestment. Repeating that pattern for three straight years points to a business that is not very capital-intensive, so routine maintenance and measured expansion do not appear to absorb much of what operations generate.

Gross margin stability around 60% through the recent dip and rebound suggests the core product economics held up better than the sales line alone would imply. What changed in FY2025 was below gross profit: SG&A and R&D rose faster than sales, so incremental revenue translated into only modest extra net income.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 23 / 100
Financial Profile 23/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Mettler-Toledo's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth
38

Mettler-Toledo's revenue grew a modest 4.0% year-over-year to $4.0B. This slow but positive growth earns a score of 38/100.

Leverage
0

Mettler-Toledo has elevated debt relative to equity (D/E of -88.35), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Liquidity
18

Mettler-Toledo's current ratio of 1.14 is below the typical benchmark, resulting in a score of 18/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
79

Mettler-Toledo converts 21.1% of revenue into free cash flow ($848.6M). This strong cash generation earns a score of 79/100.

Piotroski F-Score Neutral
6/9

Mettler-Toledo passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, all 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed
1.10x

For every $1 of reported earnings, Mettler-Toledo generates $1.10 in operating cash flow ($955.8M OCF vs $869.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$4.0B
YoY+4.0%
5Y CAGR+5.5%
10Y CAGR+5.4%

Mettler-Toledo generated $4.0B in revenue in fiscal year 2025. This represents an increase of 4.0% from the prior year.

EBITDA
N/A
Net Income
$869.2M
YoY+0.7%
5Y CAGR+7.6%
10Y CAGR+11.0%

Mettler-Toledo reported $869.2M in net income in fiscal year 2025. This represents an increase of 0.7% from the prior year.

EPS (Diluted)
$42.05
YoY+3.9%
5Y CAGR+11.0%
10Y CAGR+15.5%

Mettler-Toledo earned $42.05 per diluted share (EPS) in fiscal year 2025. This represents an increase of 3.9% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$848.6M
YoY-1.8%
5Y CAGR+6.1%
10Y CAGR+12.4%

Mettler-Toledo generated $848.6M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 1.8% from the prior year.

Cash & Debt
$66.9M
YoY+12.7%
5Y CAGR-6.6%
10Y CAGR-5.0%

Mettler-Toledo held $66.9M in cash against $2.1B in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
20M
YoY-2.8%
5Y CAGR-2.8%
10Y CAGR-3.6%

Mettler-Toledo had 20M shares outstanding in fiscal year 2025. This represents a decrease of 2.8% from the prior year.

Margins & Returns

Gross Margin
59.4%
YoY-0.7pp
5Y CAGR+1.0pp
10Y CAGR+5.5pp

Mettler-Toledo's gross margin was 59.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.7 percentage points from the prior year.

Operating Margin
N/A
Net Margin
21.6%
YoY-0.7pp
5Y CAGR+2.1pp
10Y CAGR+8.7pp

Mettler-Toledo's net profit margin was 21.6% in fiscal year 2025, showing the share of revenue converted to profit. This is down 0.7 percentage points from the prior year.

Return on Equity
N/A

Capital Allocation

R&D Spending
$199.4M
YoY+5.3%
5Y CAGR+7.3%
10Y CAGR+5.5%

Mettler-Toledo invested $199.4M in research and development in fiscal year 2025. This represents an increase of 5.3% from the prior year.

Share Buybacks
$800.0M
YoY-5.9%
5Y CAGR+0.6%
10Y CAGR+10.5%

Mettler-Toledo spent $800.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 5.9% from the prior year.

Capital Expenditures
$107.1M
YoY+3.1%
5Y CAGR+3.0%
10Y CAGR+2.7%

Mettler-Toledo invested $107.1M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 3.1% from the prior year.

MTD Income Statement

Metric Q2'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $684.3M-39.4% $1.1B+9.7% $1.0B+4.7% $983.2M+11.3% $883.7M-15.4% $1.0B+9.5% $954.5M+0.8% $946.8M
Cost of Revenue $268.6M N/A N/A N/A N/A N/A N/A N/A
Gross Profit $555.8M-17.7% $675.4M+10.8% $609.5M+5.1% $579.9M+10.3% $525.9M-17.7% $639.3M+11.7% $572.5M+1.2% $565.7M
R&D Expenses $51.3M-2.5% $52.6M+2.8% $51.1M+3.8% $49.3M+6.3% $46.3M-7.4% $50.1M+6.2% $47.1M+2.9% $45.8M
SG&A Expenses $258.3M-0.6% $259.8M+4.6% $248.4M+0.4% $247.3M+1.9% $242.8M+2.3% $237.3M+3.7% $228.8M-3.0% $235.8M
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense $17.0M-2.2% $17.4M-1.7% $17.7M+5.5% $16.8M+0.8% $16.7M-6.7% $17.9M-4.0% $18.6M-1.9% $18.9M
Income Tax $40.2M-7.2% $43.3M-16.3% $51.7M+11.7% $46.3M+20.7% $38.4M-38.4% $62.2M+31.2% $47.4M+122.0% $21.4M
Net Income $169.5M-40.7% $285.8M+31.4% $217.5M+7.5% $202.3M+23.7% $163.6M-35.2% $252.3M+19.3% $211.5M-4.6% $221.8M
EPS (Diluted) $8.33 N/A $10.57+8.3% $9.76+25.0% $7.81 N/A $9.96-4.0% $10.37

MTD Balance Sheet

Metric Q2'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $3.7B-1.2% $3.7B+5.4% $3.5B+3.6% $3.4B+5.1% $3.2B-0.2% $3.2B-2.4% $3.3B+2.2% $3.2B
Current Assets $1.3B-2.3% $1.4B+6.4% $1.3B+3.0% $1.2B+6.8% $1.2B-2.4% $1.2B-0.4% $1.2B+1.7% $1.2B
Cash & Equivalents $60.6M-9.4% $66.9M-3.2% $69.1M+11.7% $61.8M-3.8% $64.3M+8.3% $59.4M-17.1% $71.6M+1.1% $70.8M
Inventory $404.8M+4.5% $387.2M-3.6% $401.8M+3.5% $388.1M+8.2% $358.8M+4.8% $342.3M-8.9% $375.8M+2.6% $366.4M
Accounts Receivable $708.2M-9.0% $778.2M+13.2% $687.3M+0.8% $681.6M+6.8% $638.4M-7.1% $687.1M+7.8% $637.2M+0.4% $634.7M
Goodwill $736.9M-0.3% $739.2M+1.1% $731.2M+6.9% $684.1M+1.6% $673.2M+0.6% $668.9M-0.5% $672.4M+1.1% $665.4M
Total Liabilities $3.7B-0.7% $3.7B-0.9% $3.8B+3.0% $3.7B+7.1% $3.4B+1.5% $3.4B-3.1% $3.5B+2.1% $3.4B
Current Liabilities $1.1B-7.5% $1.2B+0.5% $1.2B+7.7% $1.1B-3.7% $1.1B-1.6% $1.2B-1.4% $1.2B-7.5% $1.3B
Long-Term Debt $2.2B+3.5% $2.1B-2.7% $2.1B+1.1% $2.1B+12.3% $1.9B+3.3% $1.8B-3.2% $1.9B+8.3% $1.7B
Total Equity -$41.9M-77.2% -$23.6M+90.5% -$249.2M+3.7% -$258.8M-42.2% -$182.0M-43.4% -$126.9M+17.8% -$154.4M-1.0% -$152.8M
Retained Earnings $9.4B+1.8% $9.2B+3.2% $9.0B+2.5% $8.7B+2.4% $8.5B+2.0% $8.4B+3.1% $8.1B+2.7% $7.9B

MTD Cash Flow Statement

Metric Q2'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow $139.8M-38.0% $225.6M-24.6% $299.4M+26.7% $236.4M+21.6% $194.4M-27.0% $266.2M+4.5% $254.7M-1.1% $257.5M
Capital Expenditures $17.4M-58.0% $41.5M+69.5% $24.5M+2.6% $23.9M+38.4% $17.3M-58.2% $41.3M+92.7% $21.4M-10.0% $23.8M
Free Cash Flow $122.4M-33.5% $184.1M-33.0% $274.9M+29.4% $212.5M+19.9% $177.2M-21.2% $224.9M-3.6% $233.2M-0.2% $233.7M
Investing Cash Flow -$31.3M+22.4% -$40.4M+59.2% -$98.9M-107.6% -$47.6M-589.9% -$6.9M+86.5% -$51.1M-35.6% -$37.6M-72.4% -$21.8M
Financing Cash Flow -$114.3M+40.5% -$192.1M+0.4% -$192.9M-3.7% -$186.0M-1.0% -$184.1M+17.7% -$223.7M-2.2% -$218.9M+6.6% -$234.3M
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks $206.3M+43.5% $143.7M-34.3% $218.7M0.0% $218.7M0.0% $218.7M+2.9% $212.5M0.0% $212.5M0.0% $212.5M

MTD Financial Ratios

Metric Q2'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin 81.2%+21.4pp 59.8%+0.6pp 59.2%+0.2pp 59.0%-0.5pp 59.5%-1.7pp 61.2%+1.2pp 60.0%+0.2pp 59.8%
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin 24.8%-0.5pp 25.3%+4.2pp 21.1%+0.5pp 20.6%+2.1pp 18.5%-5.6pp 24.1%+2.0pp 22.2%-1.3pp 23.4%
Return on Equity N/A N/A N/A N/A N/A N/A N/A N/A
Return on Assets 4.6%-3.1pp 7.7%+1.5pp 6.2%+0.2pp 5.9%+0.9pp 5.1%-2.7pp 7.8%+1.4pp 6.4%-0.5pp 6.8%
Current Ratio 1.20+0.1 1.14+0.1 1.07-0.0 1.12+0.1 1.010.0 1.02+0.0 1.01+0.1 0.92
Debt-to-Equity -51.61+36.7 -88.35-79.7 -8.61-0.4 -8.21+2.2 -10.39+4.0 -14.43-2.2 -12.26-0.8 -11.43
FCF Margin 17.9%+1.6pp 16.3%-10.4pp 26.7%+5.1pp 21.6%+1.6pp 20.1%-1.5pp 21.5%-2.9pp 24.4%-0.2pp 24.7%

Note: Shareholder equity is negative (-$23.6M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Frequently Asked Questions

Mettler-Toledo (MTD) reported $4.0B in total revenue for fiscal year 2025. This represents a 4.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Mettler-Toledo (MTD) revenue grew by 4% year-over-year, from $3.9B to $4.0B in fiscal year 2025.

Yes, Mettler-Toledo (MTD) reported a net income of $869.2M in fiscal year 2025, with a net profit margin of 21.6%.

Mettler-Toledo (MTD) reported diluted earnings per share of $42.05 for fiscal year 2025. This represents a 3.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, Mettler-Toledo (MTD) had $66.9M in cash and equivalents against $2.1B in long-term debt.

Mettler-Toledo (MTD) had a gross margin of 59.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Mettler-Toledo (MTD) had a net profit margin of 21.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Mettler-Toledo (MTD) generated $848.6M in free cash flow during fiscal year 2025. This represents a -1.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Mettler-Toledo (MTD) generated $955.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Mettler-Toledo (MTD) had $3.7B in total assets as of fiscal year 2025, including both current and long-term assets.

Mettler-Toledo (MTD) invested $107.1M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Mettler-Toledo (MTD) invested $199.4M in research and development during fiscal year 2025.

Yes, Mettler-Toledo (MTD) spent $800.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Mettler-Toledo (MTD) had 20M shares outstanding as of fiscal year 2025.

Mettler-Toledo (MTD) had a current ratio of 1.14 as of fiscal year 2025, which is considered adequate.

Mettler-Toledo (MTD) had a debt-to-equity ratio of -88.35 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Mettler-Toledo (MTD) had a return on assets of 23.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Mettler-Toledo (MTD) has negative shareholder equity of -$23.6M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Mettler-Toledo (MTD) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Mettler-Toledo (MTD) has an earnings quality ratio of 1.10x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Mettler-Toledo (MTD) scores 23 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top